HIG2

• Article
  HIG2 Protein: New Frontiers in Diagnosis
  

  02. May 2011 Authors: Hikmat A. Al-Ahmadie, Maria Tretiakova, Ph.D., MD Institutes: Memorial Sloan-Kettering Cancer Center, Department of Pathology, New York, USA, University of Chicago, Department of Pathology, Chicago, IL, USA

  Tumor hypoxia is a common phenomenon in some subtypes of renal cell carcinomas (RCC) and may play a role in their biology and response to treatment. Here we evaluate a novel hypoxia marker HIG2 in renal cortical tumors and normal tissues. Read article